Description
Composition:
Each film coated tablet contains Levofloxacin Hemihydrate INN equivalent to Levofloxacin INN 500 mg.
Indication:
LEVOSAFE is indicated in the treatment of following infections.
* Acute maxillary sinusitis
* Acute bacterial exacerbation of chronic bronchitis.
* Community acquired pneumonia.
* Complicated and uncomplicated urinary tract infection.
* Complicated and uncomplicated skin and soft tissue infection.
Dosage and administration:
* Acute sinusitis: 500 mg daily for 10-14 days.
* Acute exacerbation of chronic bronchitis : 250-500 mg daily for 7-10 days.
* Community-aquired pneumonia: 500 mg once or twice daily for 7-14 days.
* Urinary tract infection: 250 mg daily for 7-14 days.
* Uncomplicated skin and soft-tissue infections: 500 mg once daily for 7-10 days.
* Complicated skin and soft-tissue infections: 750 mg once daily for 7-14 days.
Contraindications:
LEVOSAFE is conraindicated in patients with a history of hypersensitivity to it or other quinlone antimicrobial agents.
Precautions:
LEVOSAFE should be used with caution in the presence of renal insufficiency. In patients with impaired renal function (Creatinine clearance <50 ml/min), adjustment of the dose is necessary to avoid the accumulation of Levofloxacin due to decreased clearance.
Use in pregnancy and lactation:
There are no adequate and well-controlled studies in pregnant women. LEVOSAFE may excrete in breast millk. During lactation it should not be used.
Side effects:
Cardiovascular collapse, Hypotension, Seizure, loss of consciousness, bronchospasm, acute respiratory distress, Urticaria, Vertigo.
Storage:
Keep in cool (below 300 c), dry place and away from light. How supplied: 2 x 10’s tablets in blister strip pack.
